Skip to content

New Feature: Text Message Treatment Updates

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated texts with the intention of collecting data on their medical cannabis treatment outcomes.

How It Works

When creating a new patient case, physicians input the patient’s phone number along with all other relevant information. Once a phone number is entered, a drop-down box will appear offering the physician to choose if the patient has opted in for text message updates. These text message updates will automatically be sent to the patient at a specific date and time with a request to rate their treatment efficacy on a scale of one (Adverse Reaction) to five (Total Resolution of Symptoms). All the patient will then have to do is respond with a number (1 through 5), and the data is collected in their case file.

The Benefit

“We want to ensure that physicians have real-time responses from their patients about their medical cannabis treatment plans,” said James West, founder and CEO of Arfinn Med. “Several states have long durations between required appointments, so physicians need to have tools to track their patients’ progress and create an open dialogue during a treatment period to increase the likelihood that the treatment plan will be further customized for the patient.”

Providing this type of feature will significantly save physicians time when collecting updates from patients. Instead of lengthy office visits or following up via phone call, one text can collect all the information needed. All data received through this text messaging feature is a real time update to help give a full picture of how that specific treatment is affecting each patient. Along with saving both the physician and patient time, this feature is also expected to increase patient retention. With such a hands-on approach, the text messaging feature will encourage patients to keep their physicians updated and refine the treatment plan, if/as needed, to obtain the results they desire.


At Arfinn Med, we are dedicated to helping medical professionals and their patients combat debilitating diseases and conditions with the use of medical marijuana. By relying on actual physician observations regarding patient outcomes, doctors can create reports based on the effectiveness, daily dosage and delivery mode of cannabis treatments specific to various patient demographics. Are you ready to join a nationwide network of medical professionals to learn more about medical marijuana and what it can do for your patients? Join Arfinn Med for FREE today!

Stories you may be interested in

LEGALIZING CANNABIS LINKED TO LESS OPIOID PRESCRIPTIONS, COULD HELP COMBAT EPIDEMIC, SCIENTISTS SAY

There are less opioid prescriptions on average in U.S. states where medical and recreational marijuana are legal, research has revealed. Access to recreational cannabis in the U.S. was tied with a 11.8 percent lower rate of opioids prescriptions each day, and 4.2 percent for medical marijuana. The authors of the paper published in the Journal of Health Economics said recreational weed…
Read More

PTSD: Is There Any Relief?

In honor of PTSD awareness month, let’s take a look at the debilitating mental health condition and how medical marijuana could help.Post-traumatic stress disorder is a mental health condition caused by witnessing or experiencing a traumatic event. It is understandable for one to be taken aback and impacted by a traumatic event, but if specific…
Read More

Arfinn Med March Updates

We are very happy to announce the release of several new functions within the Arfinn Med Platform.  Those include: * Text message updates from patients regarding their treatments * Templating for exam notes  * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More

Medical Marijuana Faces Acceptance Barrier by Hesitant Medical Schools

A new study shows a growing interest by university pharmacy programs in teaching about medical marijuana in their curriculum, while medical schools seem to lag behind. Sixty-two percent of U.S. pharmacy school respondents queried in a new survey said they included medical marijuana in their doctorate of pharmacy curriculum. That’s according to a nine-page study co-authored by…
Read More

IBD and Cannabinoid Medicine

With an estimated 3.1 million adults diagnosed with Irritable Bowel Disease (IBD) in the United States, it’s natural that many people are asking about the possible benefits of cannabis for the symptoms associated with IBD. In fact, the University of Michigan Health Department received so many questions regarding this issue, that they released a Q&A…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More